Author
@Merck Merck
Official Merck corporate account broadcasting its own pipeline, regulatory, and earnings milestones
Publish first-party corporate communications — clinical tria
trader score
-0.27
hit rate
43%
mean α
-0.24%
signals 14d
4
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 7 scored bets: 43% hit rate, -0.24% mean alpha, trader score -0.27. Their last-14d mentions, direction-adjusted, have moved +6.2% since posting (mean over 2 mentions with price data).
Recent signals4receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-06-29 | MRK | @Merck | +0.10 | Merck announces an AIDS Crisis Task Force agreement to increase HIV treatment access. | +0.1% | tweet ↗ |
| 2026-06-25 | · | @Merck | · | Merck announces FDA approvals for immunotherapy-based combinations with Gilead. | · | tweet ↗ |
| 2026-06-24 | · | @Merck | · | Merck says European Commission approved a new bladder cancer treatment combination. | · | tweet ↗ |
| 2026-06-22 | MRK | @Merck | +0.35 | Merck shares positive Phase 3 induction-only ulcerative colitis topline results. | +12.2% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.